President Donald J. Trump issued Executive Order (“EO”) 14293 entitled Regulatory Relief to Promote Domestic Production of ...

The U.S. Food and Drug Administration (FDA) has announced its plan to increase the use of unannounced inspections at foreign ...

The expansion builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program ...

On May 6, 2025, the U.S. Food and Drug Administration (FDA) announced that it intends to expand its use of unannounced inspections at ...

Enhertu delivered a phase 3 trial win in early-stage breast cancer. Takeda spotlighted three late-stage readouts as a ...

In a significant policy shift announced on May 6, 2025, the FDA will now conduct unannounced inspections at foreign ...

The FDA said that it plans to expand unannounced inspections at foreign sites that produce food, essential medicines and ...

The FDA says it conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 ...

The FDA is ramping up oversight of foreign manufacturing sites by expanding its use of unannounced inspections, a move aimed at leveling the playing field between domestic and international drugmakers ...

The official in charge of federal food and drug safety inspections will retire May 14. Michael Rogers, associate commissioner ...

For both foods and drugs, most foreign inspections were pre-announced; the agency also re-emphasized its ban on inspectors ...

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.